ArticleBritish journal of cancer2025

Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients.

Maud B A van der Kleij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.